Evidence map›Paper›PMID 22554779›Full record

ArticleNeuroscience2012

Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat.

G Akopian, C Crawford, G Petzinger, M W Jakowec, J P Walsh

Abstract read
In one paragraph

Article in Neuroscience, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

G AkopianDavis School of Gerontology, University of Southern California, Los Angeles, CA 90089-0191, USA.
C Crawford
G Petzinger
M W Jakowec
J P Walsh
University of Southern California · USCalifornia State University, San Bernardino · US

Funding

Mitchondrial inhibition mimics corticostriatal agingR01AG021937 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI WALSH, JOHN P · 2004 to 2009
$941k
NIA NIH HHS AG 21937NIA NIH HHS R01 AG021937
6 · The paper itself

Abstract

The striatum is particularly vulnerable to mitochondrial dysfunction and this problem is linked to pathology created by environmental neurotoxins, stimulants like amphetamine, and metabolic disease and ischemia. We studied the course of recovery following a single systemic injection of the mitochondrial complex II inhibitor 3-nitropropionic acid (3-NP) and found 3-NP caused lasting changes in motor behavior that were associated with altered activity-dependent plasticity at corticostriatal synapses in Fischer 344 rats. The changes in synapse behavior varied with the time after exposure to the 3-NP injection. The earliest time point studied, 24h after 3-NP, revealed 3-NP-induced an exaggeration of D1 Dopamine (DA) receptor dependent long-term potentiation (LTP) that reversed to normal by 48 h post-3-NP exposure. Thereafter, the likelihood and degree of inducing D2 DA receptor dependent long-term depression (LTD) gradually increased, relative to saline controls, peaking at 1 month after the 3-NP exposure. NMDA receptor binding did not change over the same post 3-NP time points. These data indicate even brief exposure to 3-NP can have lasting behavioral effects mediated by changes in the way DA and glutamate synapses interact.

Indexed as

Adrenergic AgentsAnalysis of VarianceAnimalsBenzazepinesBiophysicsCerebral CortexCorpus StriatumDizocilpine MaleateDopamine AntagonistsDose-Response Relationship, DrugElectric StimulationEnzyme InhibitorsExcitatory Amino Acid AntagonistsExcitatory Postsynaptic PotentialsFunctional LateralityIn Vitro Techniques3-nitropropionic acidAdrenergic AgentsBenzazepinesDizocilpine MaleateDopamine AntagonistsEnzyme InhibitorsExcitatory Amino Acid AntagonistsNitro CompoundsOxidopaminePropionatesSCH 23390SulpirideTritiumTyrosine 3-Monooxygenase

Identifiers

PMID22554779
PMCPMC3371111
OpenAlexW2065677917

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.